Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai School of Medicine, New York, NY, USA.
J Gynecol Oncol. 2013 Jan;24(1):21-8. doi: 10.3802/jgo.2013.24.1.21. Epub 2013 Jan 8.
To compare peri- and postoperative outcomes and complications of laparoscopic vs. robotic-assisted surgical staging for women with endometrial cancer at two established academic institutions.
Retrospective chart review of all women that underwent total hysterectomy with pelvic and para-aortic lymphadenectomy by robotic-assisted or laparoscopic approach over a four-year period by three surgeons at two academic institutions. Intraoperative and postoperative complications were measured. Secondary outcomes included operative time, blood loss, transfusion rate, number of lymph nodes retrieved, length of hospital stay and need for re-operation or re-admission.
Four hundred and thirty-two cases were identified: 187 patients with robotic-assisted and 245 with laparoscopic staging. Both groups were statistically comparable in baseline characteristics. The overall rate of intraoperative complications was similar in both groups (1.6% vs. 2.9%, p=0.525) but the rate of urinary tract injuries was statistically higher in the laparoscopic group (2.9% vs. 0%, p=0.020). Patients in the robotic group had shorter hospital stay (1.96 days vs. 2.45 days, p=0.016) but an average 57 minutes longer surgery than the laparoscopic group (218 vs. 161 minutes, p=0.0001). There was less conversion rate (0.5% vs. 4.1%; relative risk, 0.21; 95% confidence interval, 0.03 to 1.34; p=0.027) and estimated blood loss in the robotic than in the laparoscopic group (187 mL vs. 110 mL, p=0.0001). There were no significant differences in blood transfusion rate, number of lymph nodes retrieved, re-operation or re-admission between the two groups.
Robotic-assisted surgery is an acceptable alternative to laparoscopy for staging of endometrial cancer and, in selected patients, it appears to have lower risk of urinary tract injury.
比较两家学术机构的三位外科医生在四年期间采用腹腔镜与机器人辅助手术对子宫内膜癌患者进行手术分期的围手术期结果和并发症。
对在两家学术机构接受三位外科医生采用机器人辅助或腹腔镜方法进行全子宫切除术加盆腔和主动脉旁淋巴结切除术的所有女性进行回顾性图表审查。测量术中及术后并发症。次要结局包括手术时间、失血量、输血率、淋巴结检出数、住院时间以及再次手术或再次入院的需求。
共确定了 432 例病例:187 例患者采用机器人辅助手术,245 例患者采用腹腔镜分期。两组在基线特征方面具有统计学可比性。两组的术中并发症发生率相似(1.6% vs. 2.9%,p=0.525),但腹腔镜组的泌尿系统损伤发生率较高(2.9% vs. 0%,p=0.020)。机器人组的患者住院时间较短(1.96 天 vs. 2.45 天,p=0.016),但手术时间比腹腔镜组平均长 57 分钟(218 分钟 vs. 161 分钟,p=0.0001)。机器人组的转化率较低(0.5% vs. 4.1%;相对风险,0.21;95%置信区间,0.03 至 1.34;p=0.027),失血量也少于腹腔镜组(187 毫升 vs. 110 毫升,p=0.0001)。两组间输血率、淋巴结检出数、再次手术或再次入院率无显著差异。
机器人辅助手术是子宫内膜癌分期的一种可接受的腹腔镜替代方法,在选择的患者中,它似乎具有较低的泌尿系统损伤风险。